NASDAQ:FHTX

Foghorn Therapeutics Earning Date

USA |NASDAQ |USD

FHTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 4, 2021 (est) Sep 30, 2021 - $-0.63 $-3.12
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 4, 2021 (est) Sep 30, 2021 - $279.00K $179.00

Foghorn Therapeutics's next estimated earnings date (based on same quarter last year's date) is Dec 4, 2021 for the fiscal quarter ending Sep 30, 2021.

FHTX Earnings Date & History Chart

FHTX Earnings & Revenue Forecast

FHTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.64 $-0.72 $-0.53
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-2.47 $-2.65 $-2.27
Dec 2022 4 $-2.45 $-3.26 $-2.09

FHTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.65 $-0.66 $-0.65
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-2.48 $-2.50 $-2.49
Dec 2022 1 / 0 $-2.46 $-2.55 $-2.43

FHTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $170.00K $0.00 $500.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $1.19M $560.00K $2.00M
Dec 2022 4 $2.00M $0.00 $6.00M

FHTX Earnings Date & Revenue History

FHTX Earnings History

|
Show More
Show More

FHTX Revenue History

|
Show More
Show More

Foghorn Therapeutics Next Earnings Date & Report

FHTX Aug 2021 (FQ) Earnings Date & Report Preview

FHTX's next estimated earnings date (based on same quarter last year's report date) is Dec 4, 2021 for the fiscal quarter ending Sep 30, 2021.

Foghorn Therapeutics Previous Earnings Dates & Reports

FHTX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Foghorn Therapeutics's previous earnings date was Aug 10, 2021 for its fiscal quarter ended Jun 30, 2021.

FHTX's earnings per share (EPS) was $-0.63, missing the consensus analysts forecast of $-0.60 by -5.88%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 1.61%.

Revenues were $279.00K.

The company reported a net income of $-23.11M.

Free cash flow for the quarter was $-19.69M , compared to $-24.94M last quarter and $-14.84M a year before.

FHTX ended the quarter with $81.77M in total debt, a decrease of -0.76% compared to the previous quarter, and an increase of 24.46% compared to the same quarter a year before.

FHTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Foghorn Therapeutics's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.

FHTX's earnings per share (EPS) was $-4.98.

Revenues were $430.00.

The company reported a net income of $-68.80K.

Foghorn Therapeutics reported a free cash flow of $-47.47M for its fiscal year, compared to $-47.30M a year ago.

The company ended the fiscal year with $19.65M in total debt, an increase of 19.32% compared to the previous year.